Cathay Biotech Inc. (SHA:688065)
China
· Delayed Price · Currency is CNY 54.29
-0.32 (-0.59%)
Apr 22, 2025, 1:45 PM CST
Cathay Biotech Revenue
In the year 2024, Cathay Biotech had annual revenue of 2.96B CNY with 39.84% growth. Cathay Biotech had revenue of 741.40M in the quarter ending December 31, 2024, with 35.12% growth.
Revenue
2.96B
Revenue Growth
+39.84%
P/S Ratio
10.74
Revenue / Employee
1.64M
Employees
1,803
Market Cap
31.75B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wanhua Chemical Group | 178.98B |
| Baoshan Iron & Steel | 332.34B |
| Shandong Gold Mining | 82.52B |
| Ningxia Baofeng Energy Group | 32.98B |
| Hengli Petrochemical | 234.99B |
| Qinghai Salt Lake Industry Co.,Ltd | 15.13B |
| China Northern Rare Earth (Group) High-Tech Co.,Ltd | 32.97B |
| Inner Mongolia Baotou Steel Union | 68.09B |